26 results on '"Carides, George W."'
Search Results
2. Reductions in Human Papillomavirus-Disease Resource Use and Costs with Quadrivalent Human Papillomavirus (Types 6, 11, 16, and 18) Recombinant Vaccination: The FUTURE Study Economic Evaluation
3. The Impact of Losartan on the Lifetime Incidence of End-Stage Renal Disease and Costs in Patients with Type 2 Diabetes and Nephropathy
4. An economic assessment of losartan-based versus atenolol-based therapy in patients with hypertension and left-ventricular hypertrophy: Results from the losartan intervention for endpoint reduction (LIFE) study adapted to The Netherlands
5. Comparison of losartan and captopril on heart failure-related outcomes and symptoms from the losartan heart failure survival study (ELITE II)
6. Impact of indinavir on the quality of life in patients with advanced HIV infection treated with zidovudine and lamivudine
7. The Multinational Impact of Migraine Symptoms on Healthcare Utilisation and Work Loss
8. Losartan reduces the costs of diabetic end-stage renal disease: An Asian perspective
9. Continuum of Renoprotection with Losartan at All Stages of Type 2 Diabetic Nephropathy: A Post Hoc Analysis of the RENAAL Trial Results
10. Losartan and the United States costs of end-stage renal disease by baseline albuminuria in patients with type 2 diabetes and nephropathy
11. Losartan Reduces the Costs Associated With Diabetic End-Stage Renal Disease: The RENAAL study economic evaluation
12. The oral NK1 antagonist aprepitant for protection against nausea and vomiting in multiple cycles of chemotherapy
13. The Cost-Effectiveness of Losartan versus Captopril in Patients with Symptomatic Heart Failure
14. Losartan reduces the burden and cost of ESRD: Public health implications from the RENAAL study for the European Union
15. Healthcare resource use and costs associated with cervical, vaginal and vulvar cancers in a large U.S. health plan
16. Losartan: a pharmacoeconomic review
17. Cost effectiveness of losartan in patients with hypertension and LVH: an economic evaluation for Sweden of the LIFE trial
18. Cost-effective prevention of renal failure in type 2 diabetics using losartan
19. The longitudinal cost of end-stage renal disease in persons with diabetes in the United States
20. Losartan reduces the costs of diabetic end-stage renal disease: An Asian perspective.
21. A regression-based method for estimating mean treatment cost in the presence of right-censoring.
22. Population impact of losartan use on stroke in Canada
23. [Cost-effectiveness of treatment of high blood pressure with losartan in Denmark].
24. The impact of losartan on the lifetime incidence of ESRD and costs in Mexico.
25. Losartan reduces the costs associated with nephropathy and end-stage renal disease from type 2 diabetes: Economic evaluation of the RENAAL study from a Canadian perspective.
26. Impact of migraine symptoms on health care use and work loss in Canada in patients randomly assigned in a phase III clinical trial.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.